PTC Therapeutics Inc.

(PTCT) Trade

By |

Profile

PTC Therapeutics Inc is a biopharmaceutical company. It is focused on the discovery and development of orally administered, proprietary small-molecule drugs that target post-transcriptional control processes.

Contact Information

Website: www.ptcbio.com
Main Phone: +1 908 222-7000
Address: 100 Corporate Court
State: NJ
City / Town: South Plainfield
Country: USA
Postal Code: 07080

Issuer Information

Exchange: NGS
CEO: Stuart W. Peltz
Employees: 373
NAICS: Pharmaceutical Preparation Manufacturing (325412)
$ 36.26 $ -0.22 (-0.60%)
Last Price 36.26 Change $ -0.22 Change % -0.60 Tick N/A
Bid 30.15 Bid Size 100.00 Ask 42.00 Ask Size 100.00
Open 36.43 High 37.29 Low 36.10 Prev Close 36.48
Last Trade Volume 547,770 52 Wk Hi 52.95 52 Wk Low 14.56
Market Cap 1.7 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 46,445,672.00 EPS (TTM) -1.65 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 1 8
Number of Buys 0 2
Number of Sells 1 6
Net Activity -5161 -6630
Last 10 Buys Shares
Dawn Svoronos 1,000
Mark Rothera 1,000
Michael Schmertzler 1,000
Richard H. Aldrich 1,000
Richard H. Aldrich 1,000
Michael Schmertzler 1,000
Last 10 Sell Shares
Marcio Souza 1,000
Stuart W. Peltz 1,000
Neil Almstead 1,000
Neil Almstead 1,000
Christine Utter 1,000
Neil Almstead 1,000
Neil Almstead 1,000
David P. Southwell 1,000
David P. Southwell 1,000
Allan Jacobson 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 35 35 35 35
Low Target Price Estimate 15 15 15 15
Mean Target Price Estimate 22.75 22.75 22.75 22.75
Standard Deviation 9.67 9.67 9.67 9.67
Date of Most Recent Estimate 05/10/18 05/10/18 05/10/18 05/10/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 3 3 3 4
Moderate Sell 1 1 1 1
Strong Sell 1 1 1 0
Mean Rec. 3.17 3.17 3.17 2.83